Showing results (451-460 of 726) with videos related to
Sort By:
Pageof 73
Frontiers in Psychiatry|October 5, 2023
Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorderKeith G Heinzerling, Karina Sergi, Micah Linton, et al.The Breast Journal|May 12, 2001
High-Dose Chemotherapy with Peripheral Blood Stem Cell Support for Operable Locally Advanced Noninflammatory Carcinoma of the BreastLee S. Schwartzberg, Charles H. Weaver, Luis Campos, et al.Journal of Hematotherapy|January 11, 1992
Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factorL S Schwartzberg, R Birch, B Hazelton, et al.Blood|December 23, 2006
CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymusLing Zhao, Jennifer L Cannons, Stacie Anderson, et al.Journal of Graduate Medical Education|October 7, 2011
Medicine in the 21st century: recommended essential geriatrics competencies for internal medicine and family medicine residentsBrent C Williams, Gregg Warshaw, Anne Rebecca Fabiny, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2014
Development of innate CD4+ and CD8+ T cells in Itk-deficient mice is regulated by distinct pathwaysAmanda L Prince, Zachary Kraus, Shannon A Carty, et al.Journal of Hematotherapy|June 11, 1998
Second attempts at mobilization of peripheral blood stem cells in patients with initial low CD34+ cell yieldsC H Weaver, K Tauer, B Zhen, et al.Psycho-Oncology|January 22, 2016
Analysis of the psychological impact of cancer-related symptoms on patients with non-small cell lung cancerMark S Walker, Gerhardt M Pohl, Arthur C Houts, et al.Anti-Cancer Drugs|September 23, 2003
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy StudyM S Stratton, M E Reid, G Schwartzberg, et al.Clinical Breast Cancer|November 26, 2013
Phase II trial of fulvestrant with metronomic capecitabine for postmenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancerLee S Schwartzberg, Grace Wang, Bradley G Somer, et al.Pageof 73